---
document_datetime: 2023-09-21 19:00:23
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/optisulin-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: optisulin-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 0.9466523
conversion_datetime: 2025-12-20 14:16:32.614671
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## STEPS AFTER GRANTING THE MARKETING AUTHORISATION

For procedures finalised after 1 September 2003 please refer to module 8B.

| Scope                                                                                      | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amended on   |
|--------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|-----------------------------------------|
| Demonstration of TSE compliance                                                            | II/0001              | II                       | 26/04/2001                          | -                                       |
| Change in the insulin glargine production process                                          | II/0002              | II                       | 27/06/2001                          | -                                       |
| Change to the manufacturing process for the active substance                               | II/0003              | II                       | 27/06/2001                          | -                                       |
| New presentation(s) Addition of a new volume vial of 10 ml                                 | II/0004              | II                       | 25/04/2002                          | 09/08/2002                              |
| Change in the batch size of finished product                                               | I/0005               | I/II                     | 25/04/2003                          | -                                       |
| Change in supplier of an intermediate compound used in manufacture of the active substance | I/007                | I                        | 19/07/2003                          |                                         |

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 61(3) of Directive 2001/83/EC of 6 November 2001.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.